Effects of neoadjuvant chemotherapy vs chemoradiotherapy in the treatment of esophageal adenocarcinoma: A systematic review and meta-analysis

doi:10.3748/wjg.v30.i11.1621

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1191)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

801

Figures (1-5)

Tables (1-3)

106

Sum=991

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

124

Sum=164

Mar 21, 2024 (publication date) through May 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Mar 21, 2024; 30(11): 1621-1635
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1621

Open in New Tab Full Size Figure Download Figure

Figure 1 The preferred reporting items for systematic reviews and meta-analyses flow diagram flowchart shows the number of articles (n) in the different selection stages of the selection process. AC: Adenocarcinoma; SCC: Squamous cell carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Analysis of pathological complete response. OR: Odds ratio.

Open in New Tab Full Size Figure Download Figure

Figure 3 Analysis of the 30-d mortality. nCT: Neoadjuvant chemotherapy; nCRT: Neoadjuvant chemoradiotherapy; OR: Odds ratio.

Open in New Tab Full Size Figure Download Figure

Figure 4 The Kaplan-Meier curves for the overall survival. The x-axis shows the time in month, the y-axis shows the number of patients in percentage. nCT: Neoadjuvant chemotherapy; nCRT: Neoadjuvant chemoradiotherapy; PFS: Progression-free survival.

Open in New Tab Full Size Figure Download Figure

Figure 5 Pooled hazard ratio analysis of the overall mortality. HR: Hazard ratio; HK: Hoffman-Kringle random effect model.

Citation: Csontos A, Fazekas A, Szakó L, Farkas N, Papp C, Ferenczi S, Bellyei S, Hegyi P, Papp A. Effects of neoadjuvant chemotherapy vs chemoradiotherapy in the treatment of esophageal adenocarcinoma: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(11): 1621-1635
URL: https://www.wjgnet.com/1007-9327/full/v30/i11/1621.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i11.1621